ByMyCell
PrivateLast Round
Accelerator
May 1, 2025
Total Funding Raised
$320,000
Company Overview
ByMyCell is a biotechnology company that provides genomic sequencing and data analysis services for the agricultural and research sectors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Environmental Monitoring, Cloud Infrastructure
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ByMyCell Comparables
Compare ByMyCell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GoSolos | 84% | |
| GenomaA Biotech | 79% | |
| bioMérieux | 78% |
ByMyCell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 1, 2025 | ||||
| Seed | Jan 31, 2024 | ||||
| Grant | Aug 27, 2023 | ||||
| Angel | Mar 31, 2022 |
ByMyCell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FAPESP | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors grew 31% MoM, reaching 1.8K.
- Apr 22, 2026
Monthly visitors increased 259% MoM, reaching 1.4K.
ByMyCell Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ByMyCell's valuation, stock price, and market status.
Is ByMyCell a public or private company?
ByMyCell is a private company.
What is the current stock price of ByMyCell?
ByMyCell is a private company with no public stock price. No recent secondary market data is available.
How much is ByMyCell worth (valuation)?
Valuation information for ByMyCell is not publicly available.
Can I buy ByMyCell stock?
ByMyCell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ByMyCell's last funding round?
ByMyCell's most recent funding round was Accelerator on May 1, 2025.
Who are the main investors in ByMyCell?
Key investors in ByMyCell include FAPESP.
Will ByMyCell IPO soon?
No public IPO plans have been announced for ByMyCell.
How can I track ByMyCell secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ByMyCell's secondary market activity and sign up for updates.